BJX1.F BioLife Solutions Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
32.80 EUR
Close of Nov 12, 2026
15.40 34.40
Market cap
EUR 1.60B
P/E
38.6x
P/B
4.30x
ROE
22.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BJX1.F undervalued?

Graham number
Price32.80
Graham value12.08
Premium171.5%

BJX1.F trades 171.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioLife Solutions Inc fundamental analysis

No fundamental analysis for BioLife Solutions Inc yet.

BioLife Solutions Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioLife Solutions Inc

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitiga…

Full company profile